Envisagenics Inc
Advertisement
Envisagenics Inc, based in New York, NY, is a pioneering biotechnology company that leverages its AI platform, SpliceCore, to enhance the discovery and therapeutic targeting of RNA splicing. By integrating deep expertise in RNA biology with advanced AI, the company aims to identify novel therapeutic targets in oncology and neurodegeneration that are often overlooked by conventional methods.
Dedicated to delivering transformative treatments, Envisagenics fosters a collaborative, patient-driven environment that prioritizes impactful healthcare solutions. The company's innovative approach harnesses the potential of RNA splicing to unlock breakthrough treatments for patients in need.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Advertisement